background
previou
studi
report
detect
influenza
rna
stool
patient
season
influenza
infect
detect
may
clinic
signific
factor
may
influenc
stool
posit
influenza
virus
object
object
studi
investig
demograph
clinic
microbiolog
factor
could
favor
presenc
influenza
viral
rna
stool
patient
laboratoryconfirm
influenza
infect
method
acut
respiratori
infect
ari
patient
enrol
gener
practition
gp
two
winter
season
nasopharyng
swab
stool
specimen
clinic
data
collect
sampl
test
respiratori
pathogen
group
nasopharyng
stool
specimen
enter
pathogen
stool
specimen
result
among
patient
ari
enrol
gp
present
influenza
infect
influenza
rna
detect
stool
sampl
stool
specimen
analyz
hospit
adjust
odd
ratio
aor
confid
interv
ci
p
age
year
aor
p
consumpt
raw
shellfish
andor
mollusk
aor
p
use
antibiot
aor
p
antivir
treatment
aor
p
significantli
associ
increas
odd
detect
influenza
rna
stool
among
stool
sampl
subject
viral
isol
one
show
viru
growth
conclus
find
use
studi
investig
dissemin
rout
influenza
virus
gastrointestin
tract
k
e
w
r
acut
respiratori
infect
enter
pathogen
gastrointestin
symptom
gener
practition
influenza
viru
stool
sampl
minodi
et
al
upper
respiratori
tract
viru
recogn
sialic
acid
molecul
link
gal
glycoprotein
surfac
host
epitheli
cell
howev
viral
rna
virus
detect
stool
patient
confirm
influenza
infect
overal
report
preval
although
main
rout
human
influenza
viru
infect
respiratori
gastrointestin
gi
symptom
diarrhea
nausea
vomit
abdomin
pain
uncommon
manifest
current
avian
influenza
viru
known
replic
human
intestin
tissu
caus
sever
gi
symptom
season
pandem
influenza
viru
like
spread
gi
tract
patient
primari
respiratori
infect
rout
dissemin
remain
unknown
current
knowledg
explain
detect
human
influenza
virus
fece
swallow
influenza
virus
upper
respiratori
tract
ii
remnant
infect
submucos
intestin
antigenpres
immun
cell
iii
viru
replic
intestin
cell
signific
detect
influenza
viral
rna
stool
dissemin
gi
tract
correl
gi
symptom
viabil
stool
remain
unclear
still
debat
recent
studi
report
swallow
influenza
season
virus
vulner
digest
juic
artifici
highli
viscou
mucu
imit
sputum
nasal
discharg
mucou
membran
secret
seem
protect
viral
rna
virion
allow
detect
fece
seem
import
identifi
whether
factor
would
favor
influenza
detect
stool
aim
limit
interpret
bias
futur
thu
prospect
studi
investig
first
time
microbiolog
demograph
clinic
factor
could
influenc
presenc
influenza
viral
rna
stool
patient
laboratoryconfirm
influenza
infect
result
studi
help
inform
futur
studi
investig
role
human
influenza
viru
stool
studi
approv
ethic
committe
cpp
v
ref
number
protocol
conduct
accord
helsinki
declar
sampl
code
test
anonym
none
author
collect
sampl
sampl
collect
sent
test
laboratori
gener
practition
gp
involv
research
project
patient
inform
store
accord
nation
regul
access
data
restrict
permiss
cnil
patient
ident
disclos
stage
written
inform
consent
obtain
patient
gp
children
age
parent
legal
guardian
gave
permiss
particip
project
consent
child
also
obtain
depend
herhi
age
matur
prospect
observ
crosssect
studi
conduct
patient
consult
gp
french
sentinel
network
acut
respiratori
infect
ari
two
winter
season
novemb
april
novemb
april
case
definit
ari
person
sudden
onset
symptom
least
one
follow
four
system
symptom
fever
feverish
malais
headach
myalgia
least
one
follow
three
respiratori
symptom
cough
sore
throat
short
breath
patient
recruit
within
hour
onset
symptom
two
type
sampl
obtain
enrol
patient
nasopharyng
swab
stool
sampl
nasopharyng
specimen
collect
gp
sent
case
report
form
crf
test
laboratori
post
tripl
packag
requir
unit
nation
class
specif
crf
includ
variabl
age
sex
profession
statu
season
influenza
vaccin
ari
sign
symptom
gi
symptom
presenc
chronic
diseas
risk
factor
sever
influenza
travel
day
consult
drug
consumpt
day
consult
antivir
andor
antibiot
andor
antiinflammatori
andor
antipyret
andor
consumpt
particular
food
tap
water
oyster
mussel
andor
shellfish
cook
raw
depress
drug
prescript
requir
hospit
includ
patient
ask
collect
stool
specimen
send
laboratori
within
hour
gp
consult
post
tripl
packag
requir
unit
nation
class
specif
phage
ad
extract
tube
assess
qualiti
extract
end
amplif
rtqpcr
test
consid
posit
pass
intern
posit
control
exponenti
curv
sampl
exclud
intern
control
valu
cycl
threshold
ct
valu
nasopharyng
stool
specimen
posit
influenza
viru
inocul
onto
madindarbi
canin
kidney
mdck
tissu
cell
aliquot
clinic
specimen
incub
day
use
method
report
previous
detail
result
microbiolog
investig
present
bivari
associ
rna
detect
influenza
viru
stool
yesno
laboratoryconfirm
influenza
patient
demograph
clinic
manag
factor
present
tabl
patient
consum
raw
shellfish
andor
mollusk
multivari
analys
report
hospit
aor
p
significantli
associ
fecal
viral
rna
detect
tabl
three
patient
fecal
viral
rna
posit
hospit
id
patient
id
patient
id
patient
tabl
tabl
note
confid
interv
quit
larg
due
small
sampl
size
result
present
studi
suggest
age
hospit
food
drug
consumpt
seem
modifi
odd
detect
influenza
rna
stool
laboratoryconfirm
influenza
patient
howev
microbiolog
clinic
characterist
influenza
viru
type
ct
mean
valu
gi
symptom
seem
associ
influenza
rna
posit
stool
specimen
howev
report
success
recoveri
viabl
influenza
viru
stool
boost
hypothesi
intestin
cell
could
support
replic
influenza
season
virus
overal
proport
influenza
viral
rna
stool
specimen
report
present
studi
line
report
recent
metaanalysi
ci
studi
fecal
viral
rnaposit
detect
rang
children
age
less
year
adult
belong
age
group
observ
belong
age
group
year
hospit
increas
odd
detect
influenza
viru
stool
line
previou
studi
report
posit
fecal
viral
rna
associ
stool
hospit
adult
patient
detect
rate
patient
age
year
sourc
influenza
virus
fece
virus
pass
gastrointestin
tract
poorli
understood
swallow
influenza
virus
upper
respiratori
tract
hematogen
dissemin
organ
infect
lymphocyt
sever
influenza
case
possibl
explan
fecal
viral
rna
detect
increas
odd
hospit
patient
influenza
rnaposit
stool
seem
agreement
hematogen
dissemin
influenza
virus
sever
case
high
viral
load
posit
associ
consumpt
raw
shellfish
andor
mollusk
andor
antibiot
andor
antivir
administr
observ
three
factor
known
increas
risk
diarrhea
vomit
mild
stomach
symptom
result
disrupt
normal
microflora
drug
consumpt
presenc
enter
pathogen
toxin
food
even
intoler
certain
seafood
similar
studi
associ
found
gi
symptom
influenza
detect
interestingli
among
four
patient
influenza
rna
exclus
stool
consum
raw
shellfish
andor
mollusk
three
report
gi
symptom
none
enter
pathogen
screen
detect
stool
symptom
could
caus
enter
pathogen
allergi
intoler
toxin
respons
gi
symptom
present
shellfish
mollusk
among
patient
antibiot
antivir
drug
prescript
collect
data
gi
symptom
develop
gp
consult
stool
sampl
collect
day
gp
consult
therefor
patient
start
antibiot
andor
antivir
treatment
time
stool
collect
could
make
assumpt
disrupt
gut
microflora
lead
increas
swallow
gastric
flu
help
influenza
virus
reach
lower
gastrointestin
tract
recent
studi
report
swallow
influenza
virus
becom
resist
simul
gastric
acid
bilepancreat
juic
could
detect
stool
certain
protect
mechan
viscou
mucu
protect
degrad
gi
tract
limit
studi
includ
observ
studi
design
residu
bia
exclud
small
sampl
size
result
wide
confid
interv
carri
patient
followup
collect
clinic
inform
gp
consult
detect
influenza
viru
stool
specimen
may
reduc
due
inhibitori
materi
present
gastrointestin
tract
stool
ct
valu
semiquantit
measur
viral
load
thu
imposs
assign
specif
viral
load
pathogen
notwithstand
limit
first
prospect
multicent
studi
standard
patient
screen
central
